https://www.selleckchem.com/pr....oducts/gs-441524.htm
6% to 15.6%; = .001) and a significant decrease in the percent of patients screened using CTC (3.8 % to 1.5%; = .004), FIT (9.3% to 4.9%; = .003), and sigmoidoscopy (2.4% to 1.5%, = .024). There was a nonsignificant decrease in the percent use of screening colonoscopy, from 82.9 % to 76.5% ( = .313). While the overall colorectal cancer screening rate did not increase after the USPSTF update with additional recommended screening tests, practice patterns did change with a shift in the type of screening test used. While the overall
Like
Comment
Share
